NCT04935255View on ClinicalTrials.gov

Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
Testicular Cancer
Interventions
OTHER

Blood sampling - Pharmacokinetic assessment

Two pharmacokinetic assessments will be performed (on day 2 and day 4). Each pharmacokinetic assessment consists of 10 samples (5 ml blood).

Trial Locations (1)

6500HB

Radboud UMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04935255 - Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe | Biotech Hunter | Biotech Hunter